Small Molecule Kinase Inhibitors with In Vitro β‐Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning
ChemMedChem · 2026
DOI: 10.1002/cmdc.202500756 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Jessica L Thibaud und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Polymer Science, Stellenbosch University, Stellenbosch, South Africa. Hauptthemen laut MEDLINE: Plasmodium falciparum, Machine Learning, Protein Kinase Inhibitors, Cyclic GMP-Dependent Protein Kinases. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, NIAID.
Abstract (Originalsprache)
Using a combination of molecular docking and machine learning, the BioVision Protein Kinase Inhibitor library was screened for potential inhibitors with dual activity against two Plasmodium falciparum targets, β‐hematin (synthetic hemozoin) formation and cGMP‐dependent protein kinase ( Pf PKG). Three compounds with promising activity against both targets were identified. Derazantinib is the most potent hit compound with IC 50 values of 88 µM for inhibition of β‐hematin formation (compared to 22 μM for chloroquine) and 0.160 µM against Pf PKG. Pazopanib (β‐hematin IC 50 : 219 µM and Pf PKG IC 50 : 0.330 µM) and afatinib (234 and 2.61 µM, respectively) showed more moderate activity profiles against both targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Polymer Science, Stellenbosch University, Stellenbosch, South Africa.
- Holistic Drug Discovery and Development Centre (H3D), University of Cape Town, Cape Town, South Africa.
- Department of Chemistry, University of Cape Town, Cape Town, South Africa.
- South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
- GenAIRx, Toronto, Ontario, Canada.
ORCID-Profile: Katherine A de Villiers
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- NIAID
Zitieren
APA
Thibaud, J. L., Salomane, N., Harries, S., Wicht, K. J., Coulson, L. B., Kuter, D., Chibale, K., & de Villiers, K. A. (2026). Small Molecule Kinase Inhibitors with In Vitro β‐Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning. ChemMedChem. https://doi.org/10.1002/cmdc.202500756
Vancouver
Thibaud JL, Salomane N, Harries S, Wicht KJ, Coulson LB, Kuter D, et al. Small Molecule Kinase Inhibitors with In Vitro β‐Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning. ChemMedChem. 2026. doi:10.1002/cmdc.202500756
BibTeX
@article{Thibaud2026,
author = {Thibaud, Jessica L and Salomane, Nicolaas and Harries, Sarah and Wicht, Kathryn J and Coulson, Lauren B and Kuter, David and Chibale, Kelly and de Villiers, Katherine A},
title = {Small Molecule Kinase Inhibitors with In Vitro β‐Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.202500756}
}
EUVIMED